Dynamic monitoring of glucagon secretion from living cells on a microfluidic chip

被引:41
作者
Shackman, Jonathan G. [2 ]
Reid, Kendra R. [2 ]
Dugan, Colleen E. [2 ]
Kennedy, Robert T. [1 ,2 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Electrophoresis; Immunoassay; Cells on chips; Microfluidics; Glucagon; CAPILLARY-ELECTROPHORESIS; PANCREATIC-ISLETS; ALPHA-CELLS; INSULIN; LANGERHANS; SYSTEM; DEVICE; IMMUNOASSAYS; PERFUSION; RELEASE;
D O I
10.1007/s00216-012-5755-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid microfluidic based capillary electrophoresis immunoassay (CEIA) was developed for on-line monitoring of glucagon secretion from pancreatic islets of Langerhans. In the device, a cell chamber containing living islets was perfused with buffers containing either high or low glucose concentration. Perfusate was continuously sampled by electroosmosis through a separate channel on the chip. The perfusate was mixed on-line with fluorescein isothiocyanate-labeled glucagon (FITC-glucagon) and monoclonal anti-glucagon antibody. To minimize sample dilution, the on-chip mixing ratio of sampled perfusate to reagents was maximized by allowing reagents to only be added by diffusion. Every 6 s, the reaction mixture was injected onto a 1.5-cm separation channel where free FITC-glucagon and the FITC-glucagon-antibody complex were separated under an electric field of 700 V cm(-1). The immunoassay had a detection limit of 1 nM. Groups of islets were quantitatively monitored for changes in glucagon secretion as the glucose concentration was decreased from 15 to 1 mM in the perfusate revealing a pulse of glucagon secretion during a step change. The highly automated system should be enable studies of the regulation of glucagon and its potential role in diabetes and obesity. The method also further demonstrates the potential of rapid CEIA on microfluidic systems for monitoring cellular function.
引用
收藏
页码:2797 / 2803
页数:7
相关论文
共 31 条
[1]   Glucagon antagonism as a potential therapeutic target in type 2 diabetes [J].
Bagger, J. I. ;
Knop, F. K. ;
Holst, J. J. ;
Vilsboll, T. .
DIABETES OBESITY & METABOLISM, 2011, 13 (11) :965-971
[2]   Microfluidic cell arrays for metabolic monitoring of stimulated cardiomyocytes [J].
Cheng, Wei ;
Klauke, Norbert ;
Smith, Godfrey ;
Cooper, Jonathan M. .
ELECTROPHORESIS, 2010, 31 (08) :1405-1413
[3]   Reversibly sealed multilayer microfluidic device for integrated cell perfusion and on-line chemical analysis of cultured adipocyte secretions [J].
Clark, Anna M. ;
Sousa, Kyle M. ;
Chisolm, Claire N. ;
MacDougald, Ormond A. ;
Kennedy, Robert T. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 397 (07) :2939-2947
[4]  
D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x
[5]   Quantitative Monitoring of Insulin Secretion from Single Islets of Langerhans in Parallel on a Microfluidic Chip [J].
Dishinger, John F. ;
Reid, Kendra R. ;
Kennedy, Robert T. .
ANALYTICAL CHEMISTRY, 2009, 81 (08) :3119-3127
[6]   Quantitative Measurement of Zinc Secretion from Pancreatic Islets with High Temporal Resolution Using Droplet-Based Microfluidics [J].
Easley, Christopher J. ;
Rocheleau, Jonathan V. ;
Head, W. Steven ;
Piston, David W. .
ANALYTICAL CHEMISTRY, 2009, 81 (21) :9086-9095
[7]   Metabolomic analysis of eukaryotic tissue and prokaryotes using negative mode MALDI time-of-flight mass spectrometry [J].
Edwards, JL ;
Kennedy, RT .
ANALYTICAL CHEMISTRY, 2005, 77 (07) :2201-2209
[8]   Cells on chips [J].
El-Ali, Jamil ;
Sorger, Peter K. ;
Jensen, Klavs F. .
NATURE, 2006, 442 (7101) :403-411
[9]   β-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release [J].
Franklin, I ;
Gromada, J ;
Gjinovci, A ;
Theander, S ;
Wollheim, CB .
DIABETES, 2005, 54 (06) :1808-1815
[10]   Rapid simultaneous determination of glucagon and insulin by capillary electrophoresis immunoassays [J].
German, I ;
Kennedy, RT .
JOURNAL OF CHROMATOGRAPHY B, 2000, 742 (02) :353-362